Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,485 | 91 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $442.57 | 26 | $0 (2022) |
| Novo Nordisk Inc | $395.84 | 27 | $0 (2022) |
| Daiichi Sankyo Inc. | $93.31 | 4 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $78.55 | 5 | $0 (2022) |
| Abbott Laboratories | $69.07 | 4 | $0 (2023) |
| TherapeuticsMD, Inc. | $55.19 | 4 | $0 (2022) |
| Veloxis Pharmaceuticals, Inc. | $51.45 | 2 | $0 (2019) |
| OPKO Pharmaceuticals, LLC | $33.28 | 2 | $0 (2019) |
| Currax Pharmaceuticals LLC | $29.77 | 2 | $0 (2022) |
| Amarin Pharma Inc. | $28.09 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $43.93 | 2 | Actelion Pharmaceuticals US, Inc. ($22.27) |
| 2022 | $415.60 | 25 | Novo Nordisk Inc ($147.51) |
| 2021 | $460.85 | 32 | AbbVie Inc. ($265.50) |
| 2020 | $103.93 | 6 | TherapeuticsMD, Inc. ($40.12) |
| 2019 | $261.03 | 13 | Daiichi Sankyo Inc. ($70.00) |
| 2018 | $90.34 | 5 | AbbVie, Inc. ($35.66) |
| 2017 | $109.02 | 8 | Novo Nordisk Inc ($51.24) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Cardiology | ||||||
| 01/17/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Diabetes Care | ||||||
| 12/02/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: Cardiovascular | ||||||
| 11/30/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.96 | General |
| 09/30/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.21 | General |
| 08/26/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.16 | General |
| 07/04/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Diabetes Care | ||||||
| 06/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardio-renal | ||||||
| 05/19/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: WOMENS HEALTH | ||||||
| 05/13/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.42 | General |
| 05/11/2022 | TherapeuticsMD, Inc. | ANNOVERA (Drug), IMVEXXY, BIJUVA | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: OBSTETRICS GYNECOLOGY WOMEN'S HEALTH | ||||||
| 05/04/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Cardiovascular | ||||||
| 04/22/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.12 | General |
| 04/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardio-renal | ||||||
| 04/13/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: WOMENS HEALTH | ||||||
| 04/12/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.73 | General |
| 04/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: PRIMARY CARE | ||||||
| 03/30/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: WOMENS HEALTH | ||||||
| 03/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardio-renal | ||||||
| 03/23/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: WOMENS HEALTH | ||||||
| 03/07/2022 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Obesity | ||||||
| 03/04/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.73 | General |
| 02/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Cardio-renal | ||||||
| 02/11/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.79 | General |
| 01/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 35 | 35 | $2,365 | $1,349 |
| 2022 | 4 | 156 | 162 | $15,595 | $7,341 |
| 2021 | 4 | 137 | 149 | $15,537 | $7,532 |
| 2020 | 4 | 136 | 140 | $12,633 | $6,373 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 18 | 18 | $1,260 | $723.96 | 57.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 17 | 17 | $1,105 | $625.09 | 56.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 60 | 60 | $4,200 | $2,414 | 57.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 61 | 61 | $3,965 | $2,261 | 57.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 24 | $5,016 | $1,712 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 17 | $2,414 | $954.27 | 39.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 24 | $5,016 | $2,150 | 42.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 48 | 48 | $3,360 | $1,950 | 58.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 49 | 49 | $3,185 | $1,821 | 57.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 28 | $3,976 | $1,612 | 40.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 53 | 53 | $3,710 | $2,156 | 58.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 55 | 55 | $3,575 | $2,111 | 59.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 20 | $2,840 | $1,102 | 38.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 12 | $2,508 | $1,004 | 40.0% |
About Dr. Teressa Mchenry, MD
Dr. Teressa Mchenry, MD is a Obstetrics & Gynecology healthcare provider based in Jenks, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538195292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Teressa Mchenry, MD has received a total of $1,485 in payments from pharmaceutical and medical device companies, with $43.93 received in 2023. These payments were reported across 91 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,485).
As a Medicare-enrolled provider, Mchenry has provided services to 464 Medicare beneficiaries, totaling 486 services with total Medicare billing of $22,595. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Jenks, OK
- Active Since 06/24/2006
- Last Updated 09/16/2015
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1538195292
Products in Payments
- LO LOESTRIN FE (Drug) $240.04
- INJECTAFER (Drug) $93.31
- Kerendia (Drug) $78.55
- Ozempic (Drug) $78.40
- Orilissa (Drug) $72.41
- ORILISSA (Drug) $71.94
- Envarsus (Drug) $51.45
- Victoza (Drug) $49.33
- LILETTA (Drug) $42.39
- Rayaldee (Drug) $33.28
- FreeStyle Libre Pro (Device) $33.11
- CONTRAVE (Drug) $29.77
- ANNOVERA (Drug) $28.30
- Vascepa (Drug) $28.09
- IMVEXXY (Drug) $26.89
- WATCHMAN (Device) $23.94
- APTIMA (Device) $23.25
- EVENITY (Biological) $23.14
- UPTRAVI (Drug) $22.27
- FREESTYLE LIBRE 3 (Device) $21.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.